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Neurons in the dorsal motor nucleus of the vagus (DMNV) are more severely affected by
axonal injury than most other nerves, such as those of the hypoglossal nucleus. However,
the mechanism underlying such a response remains unclear. In this study, we compared the
expression of fibroblast growth factor 1 (FGF1), a neurotrophic factor, between the DMNV
and the hypoglossal nucleus by RT-PCR and immunohistochemical analyses. RT-PCR
showed that the level of FGF1 mRNA expression in the DMNV was lower than that in the
hypoglossal nucleus (P0.01). Immunohistochemistry revealed that FGF1 was localized to
neurons. FGF1-positive neurons in large numbers were evenly distributed in the hypoglossal
nucleus, whereas FGF1-positive neurons were located in the lateral part of the DMNV.
Double immunostaining for FGF1 and choline acetyltransferase demonstrated that 22.7%
and 78% of cholinergic neurons were positive for FGF1 in the DMNV and hypoglossal nu-
cleus, respectively. A tracing study with cholera toxin B subunit (CTb) demonstrated that
cholinergic neurons sending their axons from the DMNV to the superior laryngeal nerve
were FGF1-negative. The results suggest that the low expression of FGF1 in the DMNV is
due to severe damage of neurons in the DMNV.
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I. Introduction
The dorsal motor nucleus of the vagus (DMNV) con-
tains preganglionic parasympathetic neurons sending their
axons to the peripheral organs. These preganglionic neurons
are affected by axonal injury much more severely than most
other nerves [13, 15]. Navaratnam et al. reported that only
25% of neurons remain in rat 18 months after the injury of
the vagal nerve, whereas 75% of the neurons in the hypo-
glossal nucleus survive after the axonal injury [15]. The
reason why neurons in the DMNV are more severely dam-
aged by axonal injury remains unclear. However, there is a
possibility that some growth factors are involved in the de-
generative and regenerative processes that follow the axonal
injury. Among growth factors, fibroblast growth factors
(FGFs) are of great interest, because of their abundance
in the brain and their potent trophic effect on neurons [re-
viewed in 1 and 17].
FGF1, a member of the FGF family, is a strong mitogen
for glial cells and exerts potent trophic effects on neurons [4,
10, 12, 18]. Jacques et al. demonstrated that exogenous
FGF1 increased the number of axons regenerating the in-
jured vagal nerve and the number of neurons surviving in the
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DMNV at nine weeks after injury [10]. Since FGF1 lacks the
signal peptide, FGF1 is thought to be released upon cellular
injury and to have a trophic effect on damaged neurons [3,
9]. If this is true, the expression of FGF1 should be at a rela-
tively low level in neurons of the DMNV as compared to
neurons of other cranial nuclei, such as the hypoglossal
nucleus. To test this hypothesis, we have compared the level
of expression of FGF1 in the DMNV and in the hypoglossal
nucleus by reverse transcription-polymerase chain reaction
(RT-PCR) and immunohistochemical analyses.
II. Materials and Methods
Animals
This study was performed in accordance with the PHS
Policy on Humane Care and Use of Laboratory Animals, the
NIH Guide for the Care and Use of Laboratory Animals, and
the Animal Welfare Act (7 U.S.C. et seq.). The animal use
protocol was approved by the Institutional Animal Care and
Use Committee (IACUC) of Shiga University of Medical
Science. Four Wistar rats weighing 200–250 g were used in
this experiment. The animals were housed with food and wa-
ter available ad libitum under 12:12 hr light-dark schedule.
RNA analysis
Four rats were used for RNA analysis. Under sodium
pentobarbital anesthesia (80 mg/kg), the animals were per-
fused via the ascending aorta with 10 mM phosphate buff-
ered saline (PBS), pH 7.4. The brain was dissected out and
quickly frozen. Samples were cut into 40 m thick sections
and mounted on sterilized silane-coated glass slides. The
regions of the DMNV and of the hypoglossal nucleus
were punched out under a dissection microscope. Total RNA
was isolated from both the regions using TRIzol reagent
(Life Technology, Rockville, MD, USA). Prior to reverse
transcription, the total RNA was incubated for 1 hr with 10
units of RNase-free DNase I (Amersham Biosciences Corp.)
and 20 units of recombinant RNase inhibitor (Wako Pure
Chemicals, Osaka, Japan) at 37C, to eliminate any trace of
contaminating DNA. Five µg of total RNA was then reverse-
ly transcribed for the first strand cDNA synthesis using 80
units of SuperScript II (Gibco BRL, Gaithersburg, MD) and
500 pmol of oligo dT12–18 (Amersham Biosciences Corp.) as
primers.
The PCR primers used in this study are summarized in
Table 1. -actin mRNA was amplified as an internal control
of variable mRNA amounts. The primers for -actin PCR
were designed to encompass different exons, and were ex-
pected to yield a 266 bp PCR fragment. The reaction mixture
for PCR consisted of 2 ng/l of the template cDNA, 0.8 M
each of the primers, 0.2 mM of each of four deoxynucleotide
triphosphates and 2.0 U Taq polymerase (AmpliTaqGold,
Perkin Elmer Japan Co., Tokyo, Japan) dissolved in 1PCR
buffer containing 1.5 mM MgCl2. After heat activation for
10 min at 95C, the sample was amplified using the follow-
ing profile of thermal cycle: (1) denaturation at 95C for 30
sec, (2) annealing at 56C for 30 sec, and (3) extension at
72C for 60 sec. We performed the PCR for 28–30 cycles.
The PCR products obtained were electrophoresed on a 3%
agarose gel and stained with ethidium bromide. The staining
intensity and area of each fragment were measured by an
image analyzer (FMBIO-100, Hitachi Software Engineering
Inc., Yokohama, Japan). The relative mRNA level in each
band was calculated by comparison with the expression
level of the endogenous control -actin mRNA, which was
used as an endogenous control. The normality of the data
was first assessed by F-test. F-test showed that P values for
the levels of FGF1 and choline acetyltransferase (ChAT)
and for the ratio of FGF1 to ChAT were 0.0655, 0.4230,
and 0.3915, respectively. The mRNA levels of the DMNV
and hypoglossal nucleus were then compared in four rats
using Student’s t-test. Results were considered significant
at P0.05.
Tissue preparations for immunohistochemistry
Five Wistar rats weighing 200–250 g were used in this
experiment. Under deep anesthesia with sodium pento-
barbital (80 mg/kg body weight), the animals were trans-
cardially perfused with 10 mM PBS followed by ice-cold
4% formaldehyde (FA) in 0.1 M phosphate buffer (PB),
pH 7.4. The medulla oblongata was then removed from
each animal. The specimens were postfixed for 3 days in the
same fixative as used in perfusion, and then immersed for
24 hr in 0.1 M PB containing 15% sucrose and 0.1% sodium
azide for cryoprotection. The medulla oblongatae were cut
into 20 m-thick sections using a cryostat. Before staining,
these sections were kept for at least 4 days at 4C in 0.1 M
PBS, pH 7.4, containing 0.3% Triton X-100 (PBST).
Table 1. PCR primers used in this study
Gene Primer Sequence Corresponding gene sequence Product size 
(GenBank file)
FGF1 Upper 5'-ATGGCCGAAGGGGAGATCACAACC-3' sense to 267–290 468 bp
Lower 5'-TTAGTCAGAAGATACCGGGAGGGG-3' antisense to 711–734 (RNHBGF1)
ChAT Upper 5'-TTCTTTGTCTTGGATGTTGTCAT-3' sense to 610–632 529 bp
Lower 5'-AACATTTCAACCTCAACCTTCTGG-3' antisense to 1115–1138 (from ATG codon*)
-Actin Upper 5'-GACCTCTATGCCAACACAGTGCTGT-3' sense to 2754–2778 259 bp**
Lower 5'-CTAGAAGCATTTGCGGTGCACGATG-3' antisense to 3108–3132 (RATACCYB)
* refers to references 2 and 7, ** excluding intron E.FGF1 in the DMV 3
Primary antibody
The specificity and characterization of the antibodies
were done using Western blot analysis and an immuno-
absorption test.
Western blot analysis and immunoabsorption test
For Western blots, a male Wistar rat weighing 250 g
was perfused with 10 mM PBS, pH 7.4, under deep anesthe-
sia with sodium pentobarbital (80 mg/kg). The medulla ob-
longata was dissected out and homogenized in 5 volumes of
ice-cold 50 mM Tris-HCl (pH 7.4) containing 0.5% Triton
X-100 and protease inhibitors (Complete Mini, Roche Diag-
nostics, Mannheim, Germany; one tablet/10 ml). The homo-
genates were centrifuged at 12,000 g for 20 min at 4C. The
supernatants were collected as a crude protein fraction. Pro-
tein concentration was assayed using Lowry’s method [12].
Fifty g of the crude extracted protein, 50 ng of human
recombinant FGF1 (140 amino acid form, M.W. 15.8 kDa;
Wako Pure Chemicals, Osaka, Japan) and prestained Preci-
sion protein standards (Bio-Rad, Hercules, CA) were elec-
trophoresed on a 15% sodium dodecyl sulfate-polyacryla-
mide gel under a reducing condition, and then transferred
to a polyvinylidene difluoride membrane (Immobilon-P,
Millipore, Tokyo, Japan). The membrane was blocked for 1
hr with 5% skim milk in 25 mM Tris-buffered saline (TBS,
pH 7.4) at room temperature, and further incubated over-
night with the monoclonal antibody against FGF1 (1 g/ml)
in 25 mM TBS containing 1% skim milk at room tempera-
ture. After washing with 25 mM TBS containing 0.1%
Tween-20 (Bio-Rad, Hercules, CA), the membrane was re-
acted for 2 hr with a peroxidase-coupled F (ab')2 anti-mouse
IgG (Histofine, Nichirei Corp., Tokyo, Japan; diluted 1:50).
Peroxidase labeling was detected by incubating with 0.02%
3,3'-diaminobenzidine in 50 mM Tris-HCl buffer (pH 7.6)
containing 0.3% nickel ammonium sulfate.
For immunoabsorption test, the FGF1 antibody at the
same dilution as used for immunohistochemistry was pre-
incubated overnight at 4C in 0.5 ml of PBST with or
without 10 g/ml of the human recombinant FGF1. The
FGF1/IgG complex was removed by incubation for 1 hr at
room temperature with 0.5 ml of heparin-Sepharose beads
(Amersham Pharmacia Biosciences Corp., Piscataway, NJ)
and centrifugation at 15,000 rpm for 20 min at 4C. The
supernatant was used as the immunostain in the immuno-
histochemical analysis described below.
FGF1 immunohistochemistry
Before staining, the sections were incubated for 30 min
in PBST containing 0.5% hydrogen peroxide at room tem-
perature in order to quench endogenous peroxidase. After
several washes with PBST, the sections were incubated with
the mouse monoclonal antibody against FGF1 (1 g/ml) at
4C for 2 days. The sections were washed as above and in-
cubated for 1 hr with biotinylated anti-mouse IgG (diluted
1:1000 in PBST; Vector Laboratories, Burlingame, CA,
USA) at room temperature. The sections were washed as
above and incubated for 1 hr with avidin-biotinylated perox-
idase complex (diluted 1:4000 in PBST; Vector Laborato-
ries) at room temperature. After washing above, a purple
color was developed with 0.02% 3,3'-diaminobenzidine and
0.3% nickel ammonium sulfate in 50 mM Tris-HCl buffer
(pH 7.6). The free-floating sections were mounted on gela-
tin/chrome-coated glass slides and air-dried.
Double immunofluorescence for FGF1 and ChAT or pChAT
We used double immunofluorescence staining to visu-
alize FGF1 and ChAT simultaneously. The sections were
incubated for 2 days at 4C with a mixture of mouse anti-
FGF1 monoclonal antibody (1 g/ml) and goat anti-ChAT
antibody (AB-144p, diluted 1:1000; Chemicon Internation-
al, Temecula, CA, USA). The sections were incubated for 4
hr at room temperature with a mixture of Alexa 488-conju-
gated anti-mouse IgG (1:500; Molecular Probes, Eugene,
OR, USA) and Alexa 594-conjugated anti-goat IgG (1:500;
Molecular Probes). PBST was used to dilute the antibodies
and wash the sections between each step. The free-floating
sections were mounted on gelatin-coated glass slides and
examined under a confocal laser-scanning microscope (Bio-
Rad, Hercules, CA, USA) as described previously [7, 16].
Image analyses
The image data were obtained from ten sections of two
rats. We measured areas of all nucleated neurons positive for
FGF1 (87 cells in the DMNV and 261 cells in the hypo-
glossal nucleus) or ChAT (385 cells in the DMNV and 302
cells in the hypoglossal nucleus) using the National Insti-
tutes of Health Image software on a Windows computer.
After assessing the normality of the data, the statistical
differences were determined by Student’s t-test. Results
were considered significant at P0.05.
Cholera toxin B subunit (CTb) tracing
Under anesthesia with sodium pentobarbital (40 mg/kg
body weight), 1% cholera toxin B subunit (CTb; List Bio-
logical Lab., Campbell, CA, U.S.A.) was injected with a
Hamilton syringe into the right superior laryngeal nerve of
each animal as a neuronal tracer. After 5 days, the animals
were deeply anesthetized and perfused with 10 mM PBS
followed by ice-cold 4% formaldehyde in 0.1 M PB. The
medulla oblongata was removed and processed for immuno-
histochemistry as above.
Double immunofluorescence for FGF1 and CTb
For simultaneous visualization of FGF1 and CTb, we
employed a double immunofluorescence method using the
mouse anti-FGF1 antibody and goat anti-choleragenoid anti-
body. The sections were incubated for 3 days at 4C with a
mixture of the mouse anti-FGF1 antibody (1 g/ml) and goat
anti-choleragenoid antibody (diluted 1:100,000; List Bio-
logical Lab.). After washing with PBST several times, the
sections were incubated for 4 hr at room temperature with
mixture of Alexa 488 conjugated anti-mouse IgG (1:500;
Molecular Probes) and Alexa 594 conjugated anti-goat IgG
(1:500; Molecular Probes). After washing with PBST, theToyoda et al. 4
free-floating sections were mounted on gelatin-chrome-




Figure 1 shows a typical example of RT-PCR experi-
ments with primer sets for FGF1 (Fig. 1A), ChAT (Fig. 1B)
and -actin (Fig. 1C). The expression of ChAT and -actin
mRNAs appears to be almost the same in the DMNV and
the hypoglossal nucleus, whereas the expression of FGF1
mRNA appears lower in the DMNV than in the hypoglossal
nucleus. Semi-quantitation of the data showed that the
expression of FGF1 and ChAT mRNAs was lower in the
DMNV than the hypoglossal nucleus (P0.01, Table 2). The
ratio of FGF1 mRNA to ChAT mRNA was significantly
lower in the DMNV than the hypoglossal nucleus (P0.01,
Table 2).
Specificity of the FGF1 antibody
On Western blot analysis, the mouse monoclonal anti-
FGF1 antibody stained the 15.8 kDa recombinant FGF1
(140 amino acid form) and a single band with a molecular
weight of about 16.5 kDa in rat medulla oblongata (Fig. 2A).
As reported previously [18], the antibody clearly stained the
cytoplasm of some neurons (Fig. 2B), and the staining was
abolished when the antibody was preabsorbed with 10 g/ml
of FGF1 (Fig. 2C).
Distribution of FGF1 in rat DMNV and hypoglossal nucleus
Figure 3 shows the distribution of FGF1-positive neu-
rons in rat DMNV and hypoglossal nucleus. In agreement
with the RT-PCR data, there were fewer FGF1-positive neu-
rons in the DMNV than in the hypoglossal nucleus. Positive
neurons were seen mainly in the lateral part of the DMNV
(arrows in Fig. 3A and B). In the hypoglossal nucleus,
FGF1-positive neurons were evenly distributed rostro-
caudally (Fig. 3A and B).
Figure 4 shows the typical examples of double immu-
nostaining for FGF1 (green) and ChAT (red). Most of the
ChAT-positive neurons in the hypoglossal nucleus con-
tained FGF1. In the DMNV, a small number of ChAT neu-
rons in the lateral part were positive for ChAT and a large
number of ChAT-positive neurons in the medial part were
negative for FGF1 (Fig. 4). Quantitatively, 22.7% and 78%
of ChAT-positive neurons were positive for FGF1 in the
DMNV and hypoglossal nucleus, respectively (Table 3). In
the hypoglossal nucleus, areas with FGF1-positive neurons
and ChAT-positive neurons were of approximately the same
size, whereas in the DMNV, areas of FGF1-positive neurons
were significantly smaller than areas of ChAT-positive
neurons (Table 4).
We used CTb tracing to determine if in the DMNV,
cholinergic neurons sending their axon to the larynx contain
FGF1. As seen in Figure 5, FGF1-positive neurons were a
different subpopulation from CTb-positive neurons (Fig. 5).
IV. Discussion
RNA analysis
RT-PCR analysis showed that the level of FGF1
mRNA expression was lower in the DMNV than that in the
hypoglossal nucleus, while the expression of -actin mRNA
did not differ between the two nuclei. Unexpectedly, ChAT
mRNA was expressed at a lower level in the DMNV than in
the hypoglossal nucleus. The reasons behind this observa-
tion are unclear. However, because the area of the DMNV is
smaller than that of the hypoglossal nucleus, it is possible
that surrounding areas were included when we punched out
the DMNV. Thus, we calculated the ratio of FGF1 mRNA to
ChAT mRNA. The ratio was also significantly lower in the
DMNV than in the hypoglossal nucleus.
Fig. 1. RT-PCR analysis using primer sets for FGF1 (A), ChAT (B)
and -actin (C) amplification. H and D indicate samples from the
hypoglossal nucleus and the DMNV, respectively. M indicates
molecular marker.
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Characterization of FGF1 antibody
On Western blot analysis, the FGF1 monoclonal anti-
body was recognized with the 15.8 kDa of recombinant
human FGF1 (140 amino acid form) [5]. In rat medulla ob-
longata homogenate, both antibodies detected a single band
with a molecular weight of 16.5 kDa, which corresponds to
the molecular weight of a native form of FGF1 reported in
previous studies [20, 21, 22]. Although the 140 amino acid
form of FGF1 was first purified from bovine brain [5], the
native form of FGF1 is thought to be extended at the N-
terminal end [11].
To prepare the reagent for the immunoabsorption test,
we used heparin-coated sepharose beads to remove the
FGF1/FGF1 antibody complex, because FGF1 often reacts
Fig. 2. Detection of FGF1. (A) Western blot analysis of recombinant FGF1 (140 amino acid form, 15.8 kDa; lane 1) and crude protein extract
from rat medulla oblongata (50 g protein loaded; lane 2) with mouse anti-FGF1 antibody (diluted to 1 g/ml). M indicates molecular marker.
(B) Immunostaining for FGF1 in rat medulla oblongata with mouse anti-FGF1 antibody (diluted to 1 g/ml). (C) Preabsorption of the mouse
anti-FGF1 antibody with 10 g/ml of recombinant FGF1 abolishes staining of FGF1 in rat medulla oblongata.
Fig. 3. FGF1 immunoreactivity in the medulla oblongata at bregma levels of −13.30 mm (A) and 13.80 mm (B). Bar200 m.Toyoda et al. 6
with heparan sulphate in tissues. Staining of medulla oblon-
gata sections for FGF1 was abolished using the antibody
preabsorbed with 10 g/ml of FGF1. These results indicate
that the anti-FGF1 antibody stains FGF1 in rat tissues.
Comparison of FGF1 expression between the DMNV and the 
hypoglossal nucleus
The RT-PCR results were corroborated by the results of
the immunohistochemical examination, which showed a
lower expression of FGF1 in the DMNV than the hypoglos-
sal nucleus. In the hypoglossal nucleus, 78% of cholinergic
neurons were positive for FGF1, while only 22% of cholin-
ergic neurons in the DMNV contained FGF1. In the DMNV,
FGF1-positive neurons were distributed mainly in the lateral
part of the nucleus. Such areas in the DMNV contain many
preganglionic cells sending their fibers to the ileum and
colon [19]. Previous reports indicated that neurons pro-
jecting to the larynx are distributed to the rostral part of the
DMNV [6, 23], but details of the studies were not shown.
The present study, which uses CTb tracing, demonstrated
that FGF1-positive neurons were a different subpopulation
from neurons projecting their axons to the larynx.
Preganglionic neurons in the DMNV are much more
severely affected by axonal injury than most other nerves
[13, 15]. For example, eighteen months after injury of the
vagal nerve, only 25% of the neurons could be found in rat
Fig. 4. Double immunostaining for FGF1 and ChAT in the medulla oblongata. (A) FGF1-immunoreactive neurons (green) are seen in the
DMNV and hypoglossal nucleus. (B) ChAT-immunoreactive neurons (red) are observed in the DMNV and hypoglossal nucleus. (C) Merged
image of (A) and (B). Bar200 m.
Fig. 5. Double immunostaining for FGF1 and CTb in the DMNV. (A) FGF1-immunoreactive neurons (green) and (B) CTb-immunoreactive
neurons (red) are seen in the DMNV. (C) Merged image of (A) and (B). Bar200 m.
Table 3. Quantitation of FGF1 and ChAT in the DMNV and hypo-
glossal nucleus
DMNV Hypoglossal nucleus
FGF1/ChAT ChAT/FGF1 FGF1/ChAT ChAT/FGF1
22.7% 93.1% 78.0% 81.8%
Table 4. Area-frequency distribution of FGF1-positive and ChAT-
positive neurons in the DMNV and hypoglossal nucleus
DMNV (m2) Hypoglossal nucleus (m2)
FGF1 976.6373.2* 1843.4502.3
ChAT 1233.9388.5 1946.7582.2
* P0.01 (between FGF1 and ChAT-positive neurons).FGF1 in the DMV 7
DMNV, whereas 75% of the hypoglossal nucleus neurons
had survived [15]. The reason why neurons in the DMNV
are severely damaged by axonal injury remains unclear.
However, our results suggest that the low expression of
FGF1 in neurons in the DMNV may be responsible for their
susceptibility to axonal injury. The study by Jacques et al.
who reported that a single administration of FGF1 into the
injured axon of the vagus enhanced the survival of neurons
in the DMNV [10], supports this possibility. Thus, FGF1
supplementation may be useful in the treatment of vagal
nerve injury.
V. Conclusion
RT-PCR analysis and immunohistochemistry demon-
strated a lower expression of FGF1 in the DMNV than the
hypoglossal nucleus. CTb tracing confirmed that FGF1 was
not localized to cholinergic neurons sending their axon to
the larynx. Since FGF1 is released from damaged neurons
and acts as a trophic factor, the low expression of FGF1 in
the DMNV may account for the susceptibility of pregangli-
onic parasympathetic neurons to axonal injury.
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